Becton Dickinson (BDX) announced a strategic partnership with Wellstar Health System to enhance the safety and quality of medication delivery for patients across its hospitals and care facilities. announced a strategic partnership with Wellstar Health System to enhance the safety and quality of medication delivery for patients across its hospitals and care facilities. “By integrating BD Pyxis and BD Alaris technologies, Wellstar is setting an example of how health systems can achieve connected, intelligent medication management that benefits both patients and clinicians,” said Connor Bates, worldwide president for medication management solutions at Becton Dickinson. Through the collaboration, Wellstar is combining BD Pyxis Pro medication dispensing technologies with BD Alaris Infusion Systems to provide clinicians with greater accuracy and real-time visibility. Powered by artificial intelligence, the new BD Pyxis Pro Dispensing Solution with Analytics in BD Incada provides enterprise-wide visibility into medication inventory through natural-language queries, while customizable dashboards help clinicians identify trends to ensure medication availability and reduce waste.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- BDX Upcoming Earnings Report: What to Expect?
- AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
- Becton Dickinson resumed with an Outperform at Evercore ISI
- Becton Dickinson price target lowered to $163 from $189 at TD Cowen
- BD’s PosiFlush SafeScrub Study Completion: What Investors Should Watch Next
